D55.21 Anemia due to pyruvate kinase deficiency

Name of the Condition

• Anemia due to pyruvate kinase deficiency

Summary

Anemia due to pyruvate kinase deficiency is a hemolytic anemia caused by a genetic deficiency in the pyruvate kinase enzyme, which is critical for red blood cell energy production. This deficiency impairs the cell's ability to maintain structural integrity, leading to premature destruction of red blood cells. The result is reduced oxygen-carrying capacity and symptoms of anemia.

Causes

The condition arises from genetic mutations that reduce or eliminate the activity of pyruvate kinase, an enzyme essential for red blood cell metabolism and survival. These mutations are typically inherited and may be exacerbated by environmental triggers that increase metabolic stress.

Risk Factors

• Genetic predisposition (inherited pyruvate kinase deficiency)
• Exposure to oxidative stressors (e.g., certain medications, infections, or chemicals)
• Family history of hemolytic anemia
• Underlying metabolic disorders affecting glycolytic pathways

Symptoms

• Fatigue and weakness
• Pale skin or jaundice
• Shortness of breath
• Dark urine (in acute hemolysis)
• Rapid heart rate
• Enlarged spleen (splenomegaly)

Diagnosis

Diagnosis involves blood tests to assess red blood cell count, hemoglobin levels, and reticulocyte count, along with specific enzyme activity assays (e.g., pyruvate kinase levels). Additional tests may include genetic testing to confirm mutations and rule out other causes of hemolytic anemia.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Options may include blood transfusions for severe anemia, splenectomy to reduce red blood cell destruction, and supportive care such as folic acid supplementation. In some cases, bone marrow transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the deficiency and response to treatment. Mild cases may have minimal impact, while severe cases can lead to chronic anemia and complications. Regular follow-up with a hematologist is recommended to monitor blood counts and adjust treatment as needed.

Complications

• Severe anemia requiring frequent transfusions
• Gallstones (from chronic hemolysis)
• Iron overload (from repeated transfusions)
• Splenomegaly or splenic rupture
• Developmental delays in children (in severe cases)

Lifestyle & Prevention

• Avoid known triggers (e.g., certain medications, infections)
• Maintain a balanced diet rich in folic acid
• Stay hydrated and manage stress
• Follow up with healthcare providers for regular monitoring

When to Seek Professional Help

Seek immediate medical attention if experiencing severe fatigue, jaundice, dark urine, or shortness of breath, as these may indicate acute hemolysis. Regular check-ups are advised for those with a known diagnosis to monitor for complications.

Tips for Medical Coders

Document the specific enzyme deficiency (pyruvate kinase) and any associated complications or treatments. Ensure the code D55.21 is used when the anemia is explicitly due to pyruvate kinase deficiency, and verify that supporting clinical documentation aligns with the diagnosis.